These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


72 related items for PubMed ID: 10694818

  • 1. Generation of a high titre retroviral vector for endothelial cell-specific gene expression in vivo.
    Mavria G, Jäger U, Porter CD.
    Gene Ther; 2000 Mar; 7(5):368-76. PubMed ID: 10694818
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A transcriptional feedback loop for tissue-specific expression of highly cytotoxic genes which incorporates an immunostimulatory component.
    Emiliusen L, Gough M, Bateman A, Ahmed A, Voellmy R, Chester J, Diaz RM, Harrington K, Vile R.
    Gene Ther; 2001 Jul; 8(13):987-98. PubMed ID: 11438833
    [Abstract] [Full Text] [Related]

  • 7. Factors affecting retroviral vector function and structural integrity.
    McLachlin JR, Mittereder N, Daucher MB, Kadan M, Eglitis MA.
    Virology; 1993 Jul; 195(1):1-5. PubMed ID: 8391178
    [Abstract] [Full Text] [Related]

  • 8. Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter.
    Ido A, Uto H, Moriuchi A, Nagata K, Onaga Y, Onaga M, Hori T, Hirono S, Hayashi K, Tamaoki T, Tsubouchi H.
    Cancer Res; 2001 Apr 01; 61(7):3016-21. PubMed ID: 11306481
    [Abstract] [Full Text] [Related]

  • 9. High frequency expression of integrated proviruses derived from enhancer trap retroviruses.
    Sablitzky F, Jönsson JI, Cohen BL, Phillips RA.
    Cell Growth Differ; 1993 Jun 01; 4(6):451-9. PubMed ID: 8373730
    [Abstract] [Full Text] [Related]

  • 10. Melanoma-specific expression in first-generation adenoviral vectors in vitro and in vivo -- use of the human tyrosinase promoter with human enhancers.
    Lillehammer T, Tveito S, Engesaeter BO, Fodstad O, Maelandsmo GM, Engebraaten O.
    Cancer Gene Ther; 2005 Nov 01; 12(11):864-72. PubMed ID: 15891771
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A novel human suspension culture packaging cell line for production of high-titre retroviral vectors.
    Chan LM, Coutelle C, Themis M.
    Gene Ther; 2001 May 01; 8(9):697-703. PubMed ID: 11406764
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. B-cell-specific transgene expression using a self-inactivating retroviral vector with human CD19 promoter and viral post-transcriptional regulatory element.
    Werner M, Kraunus J, Baum C, Brocker T.
    Gene Ther; 2004 Jun 01; 11(12):992-1000. PubMed ID: 15029232
    [Abstract] [Full Text] [Related]

  • 18. WPRE-mediated enhancement of gene expression is promoter and cell line specific.
    Klein R, Ruttkowski B, Knapp E, Salmons B, Günzburg WH, Hohenadl C.
    Gene; 2006 May 10; 372():153-61. PubMed ID: 16488559
    [Abstract] [Full Text] [Related]

  • 19. Effects of sequences of prokaryotic origin on titer and transgene expression in retroviral vectors.
    Hlavaty J, Portsmouth D, Stracke A, Salmons B, Günzburg WH, Renner M.
    Virology; 2004 Dec 05; 330(1):351-60. PubMed ID: 15527860
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.